Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real ‐world results from 18 378 patients in Egypt

ConclusionsReal‐world experience of generic SOF‐DCV in patients with chronic HCV‐G4 proved to be safe and associated with a high SVR12 rate, in patients with different stages of fibrosis.

Source: Alimentary Pharmacology and Therapeutics - November 29, 2017 Category: Drugs & Pharmacology Authors: H. Omar, W. El Akel, T. Elbaz, M. El Kassas, K. Elsaeed, H. El Shazly, M. Said, M. Yousif, A. A. Gomaa, A. Nasr, M. AbdAllah, M. Korany, S. A. Ismail, M. K. Shaker, W. Doss, G. Esmat, I. Waked, Y. El Shazly Tags: ORIGINAL ARTICLE Source Type: research